Please try another search
Cytori Cell Research Institute, Inc., engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. Its products pipeline includes ECCI-50 for the treatment of male stress urinary incontinence and liver cirrhosis; and Cyt-006 to prevent postoperative adhesion for primary rectal cancer. The company is also conducting clinical trials/research on cell therapy for a range of diseases and applications, including anterior cruciate ligament repair, bone repair, burn scars, chronic wound healing, critical limb ischemia, anal and Crohn’s disease fistulas, erectile dysfunction, etc. It also invests in, owns, develops, leases, and manages real estate projects and hotels; and provides real estate brokerage services. The company was formerly known as FRACTALE Corporation. Cytori Cell Research Institute, Inc. was incorporated in 2004 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Go Fujimura | 51 | - | Director |
Seijiro N. Shirahama | 69 | 2020 | Director |
Shoji Matsuyama | 51 | 2009 | Outside Independent Director |
Yasushi Sakata | 48 | 2013 | Outside Independent Director |
Hirotaka Todo | 54 | 2007 | Director |
Yoshihiro Hoshino | 67 | 2019 | President, CEO & Representative Director |
Masashi Matsuyama | 51 | 2018 | Director |
Hiroshi Wakaki | 64 | 2022 | Director |
Masaru Yajima | 75 | 2018 | Director |
Toshiyasu Horie | 52 | - | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review